Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPhathom Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$1.18 | -$1.07 | -$1.11 |
| Q2 2025 | 2 | -$1.24 | -$0.91 | -$1.05 |
| Q3 2025 | 2 | -$1.16 | -$0.85 | -$0.99 |
| Q4 2025 | 2 | -$1.06 | -$0.77 | -$0.90 |
| Q1 2026 | 1 | -$0.90 | -$0.66 | -$0.77 |
| Q2 2026 | 1 | -$0.63 | -$0.46 | -$0.54 |
| Q3 2026 | 1 | -$0.43 | -$0.31 | -$0.37 |
| Q4 2026 | 1 | -$0.22 | -$0.16 | -$0.19 |
Phathom Pharmaceuticals, Inc. Earnings Date And Information
Phathom Pharmaceuticals, Inc. last posted its earnings results on Thursday, March 6th, 2025. The company reported $-0.79 earnings per share for the quarter, topping analysts' consensus estimates of $-1.29 by $0.5. The company had revenue of 29.66 M for the quarter and had revenue of 55.25 M for the year. Phathom Pharmaceuticals, Inc. has generated $-5 earnings per share over the last year ($-5.29 diluted earnings per share) and currently has a price-to-earnings ratio of -1.06. Phathom Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Phathom Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/06/2025 | Q4 2024 | -$1.29 | -$1.05 | 0.24 | $24.93 M | $29.66 M |
| 11/07/2024 | Q3 2024 | -$1.57 | -$1.32 | 0.25 | $12.61 M | $16.35 M |
| 08/08/2024 | Q2 2024 | -$1.20 | -$1.56 | -0.36 | $5.68 M | $7.32 M |
| 06/14/2024 | Q1 2024 | N/A | -$1.42 | N/A | N/A | $1.91 M |
| 06/14/2024 | Q4 2023 | N/A | -$1.39 | N/A | $400,894 | $682,000 |
| 11/09/2023 | Q3 2023 | -$0.95 | -$0.76 | 0.19 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.95 | -$0.84 | 0.11 | N/A | $0 |
| 05/10/2023 | Q1 2023 | -$1.34 | -$0.89 | 0.45 | N/A | $0 |
| 02/28/2023 | Q4 2022 | -$1.50 | -$1.54 | -0.04 | N/A | $0 |
| 11/08/2022 | Q3 2022 | N/A | -$1.54 | N/A | N/A | $0 |
| 08/02/2022 | Q2 2022 | -$1.03 | -$1.33 | -0.3 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.97 | -$1.14 | -0.17 | N/A | $0 |
| 03/01/2022 | Q4 2021 | -$0.86 | -$0.95 | -0.09 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.98 | -0.2 | N/A | $0 |
| 08/10/2021 | Q2 2021 | -$1.07 | -$1.00 | 0.07 | N/A | $0 |
| 05/11/2021 | Q1 2021 | -$1.11 | -$0.96 | 0.15 | N/A | $0 |
| 03/30/2021 | Q4 2020 | -$0.93 | -$1.58 | -0.65 | N/A | $0 |
| 11/10/2020 | Q3 2020 | -$0.68 | -$1.02 | -0.34 | N/A | $0 |
| 08/06/2020 | Q2 2020 | -$0.56 | -$0.64 | -0.08 | N/A | $0 |
| 05/12/2020 | Q1 2020 | -$0.59 | -$0.62 | -0.03 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals, Inc. Earnings: FAQ's
Phathom Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based offlast year's report dates.
In the previous quarter, Phathom Pharmaceuticals, Inc. (:PHAT) reported $-0.79 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.29 by $0.5.
The conference call for Phathom Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Phathom Pharmaceuticals, Inc.'s latest earnings report can be read online.
Phathom Pharmaceuticals, Inc. (:PHAT) has a recorded annual revenue of $55.25 M.
Phathom Pharmaceuticals, Inc. (:PHAT) has a recorded net income of $-334,326,000.Phathom Pharmaceuticals, Inc. has generated $-5.29 earnings per share over the last four quarters.
Phathom Pharmaceuticals, Inc. (:PHAT) has a price-to-earnings ratio of -1.06 and price/earnings-to-growth ratio is -0.18.